Latest Johnson & Johnson News

FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. Who gets to be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. (AP Photo/Hans Pennink)

Debate begins for who's first in line for COVID-19 vaccine

Aug. 2, 2020 7:05 AM EDT

Who gets to be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. “Not everybody’s going to like the answer,” Dr. Francis Collins, director of the National...

A skin lightening mask is applied to the face during a demonstration for the Associated Press Tuesday, July 7, 2020, at the Skin and Body International Centre in Lenasia, Johannesburg. For years, cosmetics giants Unilever and L’Oreal have marketed skin whitening creams to women across the globe with less-than-subtle ads promoting “fair skin” as more desirable than naturally darker shades. In the wake of mass protests against racial injustice in the U.S., these corporations are re-branding their skin lightening products in Africa, Asia and the Middle East, but for generations of women raised on their messaging, the new marketing is unlikely to reverse deeply rooted prejudices around “colorism”, the idea that fair skin is better than dark skin. (AP Photo/Denis Farrell)

'Whitening' creams undergo a makeover but colorism persists

Jul. 28, 2020 9:15 AM EDT

DUBAI, United Arab Emirates (AP) — The world's biggest cosmetics companies have been selling a fairy tale that often goes something like this: If your husband's lost interest in you, if your colleagues dismiss you at work, if your talents are ignored, whiten your skin to turn your love life around, boost...

Nurse Carolyn Grausgruber gives volunteer Ithaca firefighter Wade Bardo, of Erin, N.Y., an injection as the world's biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway Monday, July 27, 2020, in Binghamton, N.Y. (AP Photo/Hans Pennink)

Experimental COVID-19 vaccine is put to its biggest test

Jul. 27, 2020 8:28 PM EDT

The biggest test yet of an experimental COVID-19 vaccine got underway Monday with the first of some 30,000 Americans rolling up their sleeves to receive shots created by the U.S. government as part of the all-out global race to stop the pandemic. The glimmer of hope came even as Google, in one of the gloomiest...

Nurse Kath Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as the world's biggest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc.,  gets underway Monday, July 27, 2020, in Binghamton, N.Y. (AP Photo/Hans Pennink)

Virus vaccine put to final test in thousands of volunteers

Jul. 27, 2020 10:43 AM EDT

The world’s biggest COVID-19 vaccine study got underway Monday with the first of 30,000 planned volunteers helping to test shots created by the U.S. government -- one of several candidates in the final stretch of the global vaccine race. There’s still no guarantee that the experimental vaccine,...

FILE - This Sept. 13, 2016, file photo, shows Johnson & Johnson Band-Aid brand bandages in Surfside, Fla.  Higher prescription drug sales and lower costs for litigation drove up Johnson & Johnson's fourth-quarter profit by 32%. The world's biggest maker of health care products on Wednesday, July 15, 2020, reported net income rose nearly $1 billion, to $4.01 billion, or $1.50 per share. (AP Photo/Wilfredo Lee, File)

J&J, after surprisingly strong 2Q, ups outlook for the year

Jul. 16, 2020 11:08 AM EDT

Johnson & Johnson had a surprisingly strong second quarter and bumped up its 2020 forecast even after COVID-19 contributed to a 40% drop in U.S. medical device sales. Growing pharmaceutical sales, also in the U.S., helped the world’s biggest health products maker counter damage from the pandemic, which...

FILE - In this March 16, 2020, file photo, a subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. According to results released on Tuesday, July 14, 2020, early-stage testing showed the first COVID-19 vaccine tested in the U.S. revved up people’s immune systems the way scientists had hoped. The vaccine is made by the National Institutes of Health and Moderna Inc. (AP Photo/Ted S. Warren, File)

First COVID-19 vaccine tested in US poised for final testing

Jul. 14, 2020 7:25 PM EDT

The first COVID-19 vaccine tested in the U.S. revved up people’s immune systems just the way scientists had hoped, researchers reported Tuesday -- as the shots are poised to begin key final testing. “No matter how you slice this, this is good news,” Dr. Anthony Fauci, the U.S....

Appeals court reduces J&J talc verdict but censures company

Jun. 23, 2020 3:54 PM EDT

JEFFERSON CITY, Mo. (AP) — A Missouri appeals court has reduced a talcum powder verdict against Johnson & Johnson by more than half, even while ruling that the company knowingly sold a product that caused cancer. In the ruling announced Tuesday, the Eastern District Missouri Court of Appeals rejected...

A lab technician works during research on coronavirus, COVID-19, at Johnson & Johnson subsidiary Janssen Pharmaceutical in Beerse, Belgium, Wednesday, June 17, 2020. Janssen Pharmaceutical hopes to begin clinical trials on a potential vaccine for COVID-19 in the middle of the summer. (AP Photo/Virginia Mayo)

Race for virus vaccine could leave some countries behind

Jun. 18, 2020 7:53 AM EDT

LONDON (AP) — As the race intensifies for a vaccine against the new coronavirus, rich countries are rushing to place advance orders for the inevitably limited supply to guarantee their citizens get immunized first — leaving significant questions about whether developing countries will get any...

Simon Property, Starbucks fall; Five Below, AMC rise

Jun. 10, 2020 4:18 PM EDT

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Wednesday: Simon Property Group Inc., down $3.46 to $83.01 The nation’s biggest mall owner is backing out of a $3.6 billion deal to buy major rival Taubman Centers. Tesla Inc., up $84.38 to $1,025.05 The electric vehicle maker is...